T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease
- PMID: 31164435
- DOI: 10.1183/13993003.00388-2019
T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease
Conflict of interest statement
Conflict of interest: A. Maurac has nothing to disclose. Conflict of interest: É. Lardenois has nothing to disclose. Conflict of interest: M. Eyries has nothing to disclose. Conflict of interest: M.R. Ghigna has nothing to disclose. Conflict of interest: I. Petit has nothing to disclose. Conflict of interest: D. Montani reports grants and personal fees from Actelion and Bayer, personal fees from GSK, MSD and Pfizer, outside the submitted work. Conflict of interest: A. Guillaumot has nothing to disclose. Conflict of interest: B. Caput has nothing to disclose. Conflict of interest: F. Chabot has nothing to disclose. Conflict of interest: A. Chaouat has nothing to disclose.
Comment in
-
The ever-expanding phenotypical spectrum of human TBX4 mutations: from toe to lung.Eur Respir J. 2019 Aug 22;54(2):1901504. doi: 10.1183/13993003.01504-2019. Print 2019 Aug. Eur Respir J. 2019. PMID: 31439725 No abstract available.
-
Correspondence regarding "T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease": a single-centre case series.Eur Respir J. 2020 May 14;55(5):1902272. doi: 10.1183/13993003.02272-2019. Print 2020 May. Eur Respir J. 2020. PMID: 32409423 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous